WikiStock

Global Securities Firms Regulatory Inquiry App

English
Download
Home-News-

Avidity Biosciences And CleanSpark Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 9-June

iconBenzinga

2024-06-16 22:25

Top mid-cap performers: Avidity Biosciences, Iris Energy, Hims & Hers Health, John Wiley & Sons, Element Solutions, CleanSpark, Enovix Corp, Axcelis Tech, Intellia Therapeutics, Korn Ferry.

  These mid-cap stocks were the best performers in the last week. Are they in your portfolio?

  •   Avidity Biosciences, Inc.RNA shares jumped 50.15% following the announcement that the Phase 1/2 trial data for muscle disorder therapy yielded positive results.

  •   Iris Energy LimitedIREN shares surged 24.31% after Cantor Fitzgeraldassumed an Overweight rating on the stock and announced a $23 price target.

  •   Hims & Hers Health, Inc.HIMS shares rose 15.29%.

  •   John Wiley & Sons, Inc. WLY shares rose 14.07% after the company reported Q4 adjusted EPS and sales that beat estimates.

  •   Element Solutions Inc.ESI shares grew 13.46% after the company raised Q2 and FY24 guidance. Mizuho and BMO Capitalalso raised their price forecasts for the stock.

  •   CleanSpark, Inc.CLSK shares gained 13.31% amid strength in Bitcoin following softer-than-expected May CPI figures.

  •   Enovix CorporationENVX stock price escalated 12.97% as shares of several industrial companies gained amid overall market strength following positive inflation data.

  •   Axcelis Technologies, Inc. ACLS shares advanced 12.70% last week. Semiconductor stocks gained on softer-than-expected CPI figures, which lifted stocks on Wednesday, while AI optimism also continues to boost the sector.

  •   Intellia Therapeutics, Inc.NTLA stock price upped 12.08%.

  •   Korn FerryKFY shares increased 8.13% following the companys Q4 earnings. A couple of analysts raised the price forecasts on the stock.

Disclaimer:The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.